Leerink Partners Maintains Clover Health(CLOV.US) With Hold Rating, Cuts Target Price to $2.5Market news · 9 Aug 2025
Craig-Hallum Maintains Clover Health(CLOV.US) With Buy Rating, Announces Target Price $5Market news · 7 Aug 2025
UBS Maintains Clover Health(CLOV.US) With Hold Rating, Cuts Target Price to $3Market news · 7 Aug 2025
CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Cuts Target Price to $4.1Market news · 7 Aug 2025
Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Clover Health Investments (CLOV) and Xilio Therapeutics (XLO)TipRanks · 15 Aug 2025
Discussion
No comments yet — be the first to weigh in on CLOV.
No comments yet — be the first to weigh in on CLOV.